Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation.
Li L, Xu N, He Y, Tang M, Yang B, Du J, Chen L, Mao X, Song B, Hua Z, Tang B, Lee SM.
Li L, et al. Among authors: du j.
Neurotherapeutics. 2024 Nov 27:e00479. doi: 10.1016/j.neurot.2024.e00479. Online ahead of print.
Neurotherapeutics. 2024.
PMID: 39609160